BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 36623520)

  • 1. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
    Xu E; Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and burdens of incident diabetes in long COVID: a cohort study.
    Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2022 May; 10(5):311-321. PubMed ID: 35325624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of mental health outcomes in people with covid-19: cohort study.
    Xie Y; Xu E; Al-Aly Z
    BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study.
    Xie Y; Choi T; Al-Aly Z
    Lancet Infect Dis; 2024 Mar; 24(3):239-255. PubMed ID: 38104583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term gastrointestinal outcomes of COVID-19.
    Xu E; Xie Y; Al-Aly Z
    Nat Commun; 2023 Mar; 14(1):983. PubMed ID: 36882400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    Xie Y; Choi T; Al-Aly Z
    BMJ; 2023 Apr; 381():e074572. PubMed ID: 37161995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Outcomes in Long COVID.
    Bowe B; Xie Y; Xu E; Al-Aly Z
    J Am Soc Nephrol; 2021 Nov; 32(11):2851-2862. PubMed ID: 34470828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID after breakthrough SARS-CoV-2 infection.
    Al-Aly Z; Bowe B; Xie Y
    Nat Med; 2022 Jul; 28(7):1461-1467. PubMed ID: 35614233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
    Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK
    J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term neurologic outcomes of COVID-19.
    Xu E; Xie Y; Al-Aly Z
    Nat Med; 2022 Nov; 28(11):2406-2415. PubMed ID: 36138154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Infection With Incident Diabetes.
    Naveed Z; Velásquez García HA; Wong S; Wilton J; McKee G; Mahmood B; Binka M; Rasali D; Janjua NZ
    JAMA Netw Open; 2023 Apr; 6(4):e238866. PubMed ID: 37071420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of digestive diseases in long COVID: evidence from a population-based cohort study.
    Ma Y; Zhang L; Wei R; Dai W; Zeng R; Luo D; Jiang R; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    BMC Med; 2024 Jan; 22(1):14. PubMed ID: 38195495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
    Bowe B; Xie Y; Al-Aly Z
    Nat Med; 2022 Nov; 28(11):2398-2405. PubMed ID: 36357676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study.
    Lim JT; Liang En W; Tay AT; Pang D; Chiew CJ; Ong B; Lye DCB; Tan KB
    Clin Infect Dis; 2024 Jan; 78(1):70-79. PubMed ID: 37746872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
    Tartof SY; Malden DE; Liu IA; Sy LS; Lewin BJ; Williams JTB; Hambidge SJ; Alpern JD; Daley MF; Nelson JC; McClure D; Zerbo O; Henninger ML; Fuller C; Weintraub E; Saydah S; Qian L
    JAMA Netw Open; 2022 Aug; 5(8):e2225657. PubMed ID: 35960522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cardiovascular outcomes of COVID-19.
    Xie Y; Xu E; Bowe B; Al-Aly Z
    Nat Med; 2022 Mar; 28(3):583-590. PubMed ID: 35132265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.